All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-39493858

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	39493858	A98G	RT	gag-pol	HIV Infections	D G S C L	View
2	39493858	D67G	RT	gag-pol	HIV Infections	D G S C L	View
3	39493858	D67N	RT	gag-pol	HIV Infections	D G S C L	View
4	39493858	E138A	RT	gag-pol	HIV Infections	D G S C L	View
5	39493858	E138G	RT	gag-pol	HIV Infections	D G S C L	View
6	39493858	E138K	RT	gag-pol	HIV Infections	D G S C L	View
7	39493858	F227L	RT	gag-pol	HIV Infections	D G S C L	View
8	39493858	G190A	RT	gag-pol	HIV Infections	D G S C L	View
9	39493858	G190E	RT	gag-pol	HIV Infections	D G S C L	View
10	39493858	G190S	RT	gag-pol	HIV Infections	D G S C L	View
11	39493858	K101E	RT	gag-pol	HIV Infections	D G S C L	View
12	39493858	K101H	RT	gag-pol	HIV Infections	D G S C L	View
13	39493858	K101P	RT	gag-pol	HIV Infections	D G S C L	View
14	39493858	K101Q	RT	gag-pol	HIV Infections	D G S C L	View
15	39493858	K101T	RT	gag-pol	HIV Infections	D G S C L	View
16	39493858	K103N	RT	gag-pol	HIV Infections	D G S C L	View
17	39493858	K103R	RT	gag-pol	HIV Infections	D G S C L	View
18	39493858	K103S	RT	gag-pol	HIV Infections	D G S C L	View
19	39493858	K20T	PR	gag-pol	HIV Infections	D G S C L	View
20	39493858	K65N	RT	gag-pol	HIV Infections	D G S C L	View
21	39493858	K65R	RT	gag-pol	HIV Infections	D G S C L	View
22	39493858	K70N	RT	gag-pol	HIV Infections	D G S C L	View
23	39493858	K70R	RT	gag-pol	HIV Infections	D G S C L	View
24	39493858	K70T	RT	gag-pol	HIV Infections	D G S C L	View
25	39493858	L10F	PR	gag-pol	HIV Infections	D G S C L	View
26	39493858	L210W	RT	gag-pol	HIV Infections	D G S C L	View
27	39493858	L74I	RT	gag-pol	HIV Infections	D G S C L	View
28	39493858	M184I	RT	gag-pol	HIV Infections	D G S C L	View
29	39493858	M184V	RT	gag-pol	HIV Infections	D G S C L	View
30	39493858	M41L	RT	gag-pol	HIV Infections	D G S C L	View
31	39493858	M46I	PR	gag-pol	HIV Infections	D G S C L	View
32	39493858	M46L	PR	gag-pol	HIV Infections	D G S C L	View
33	39493858	N88S	PR	gag-pol	HIV Infections	D G S C L	View
34	39493858	P225H	RT	gag-pol	HIV Infections	D G S C L	View
35	39493858	Q58E	PR	gag-pol	HIV Infections	D G S C L	View
36	39493858	T215A	RT	gag-pol	HIV Infections	D G S C L	View
37	39493858	T215D	RT	gag-pol	HIV Infections	D G S C L	View
38	39493858	T215I	RT	gag-pol	HIV Infections	D G S C L	View
39	39493858	T215N	RT	gag-pol	HIV Infections	D G S C L	View
40	39493858	T215S	RT	gag-pol	HIV Infections	D G S C L	View
41	39493858	T74P	PR	gag-pol	HIV Infections	D G S C L	View
42	39493858	V106I	RT	gag-pol	HIV Infections	D G S C L	View
43	39493858	V106M	RT	gag-pol	HIV Infections	D G S C L	View
44	39493858	V108I	RT	gag-pol	HIV Infections	D G S C L	View
45	39493858	V179D	RT	gag-pol	HIV Infections	D G S C L	View
46	39493858	V179I	RT	gag-pol	HIV Infections	D G S C L	View
47	39493858	V179L	RT	gag-pol	HIV Infections	D G S C L	View
48	39493858	Y115F	RT	gag-pol	HIV Infections	D G S C L	View
49	39493858	Y181C	RT	gag-pol	HIV Infections	D G S C L	View
50	39493858	Y188L	RT	gag-pol	HIV Infections	D G S C L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.